67 related articles for article (PubMed ID: 21246790)
1. [Molecular characterization of epithelial ovarian borderline tumors with respect to clinical management and prognosis].
Zikán M; Pinkavová I; Sláma J; Freitag P; Janousek M; Fischerová D; Pavlista D; Cibula D
Ceska Gynekol; 2009 Dec; 74(6):427-30. PubMed ID: 21246790
[TBL] [Abstract][Full Text] [Related]
2. Triple negative epithelial ovarian cancer: "A new entity".
Jain P; Jain A; Dubashi B
Indian J Cancer; 2015; 52(2):190. PubMed ID: 26853398
[No Abstract] [Full Text] [Related]
3. [Histopathologic prognostic factors, serum markers and selected molecular biologic factors in ovarian carcinoma].
Spacek J; Jílek P; Petera J; Tesarík Z
Ceska Gynekol; 2002 Nov; 67(6):343-9. PubMed ID: 12661373
[TBL] [Abstract][Full Text] [Related]
4. The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of "borderline" ovarian tumors.
Lawrence WD
Cancer; 1995 Nov; 76(10 Suppl):2138-42. PubMed ID: 8635013
[TBL] [Abstract][Full Text] [Related]
5. Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation.
Kim KR; Choi J; Hwang JE; Baik YA; Shim JY; Kim YM; Robboy SJ
Histopathology; 2010 Oct; 57(4):587-96. PubMed ID: 20955384
[TBL] [Abstract][Full Text] [Related]
6. [Genetic aspects of malignant epithelial ovarian tumours].
Jancárková N; Krkavcová M; Janashia M; Freitag P
Ceska Gynekol; 2005 Jul; 70(4):299-306. PubMed ID: 16128132
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of ovarian cancer.
Sanseverino F; D'Andrilli G; Petraglia F; Giordano A
Anal Quant Cytol Histol; 2005 Jun; 27(3):121-4. PubMed ID: 16121632
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in ovarian cancer.
Friedlander ML
Semin Oncol; 1998 Jun; 25(3):305-14. PubMed ID: 9633842
[TBL] [Abstract][Full Text] [Related]
9. Pathology of epithelial ovarian cancer.
Tornos C; Silva EG
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):63-77. PubMed ID: 8015767
[TBL] [Abstract][Full Text] [Related]
10. The biology of ovarian cancer.
Auersperg N; Edelson MI; Mok SC; Johnson SW; Hamilton TC
Semin Oncol; 1998 Jun; 25(3):281-304. PubMed ID: 9633841
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of ovarian cancer].
Jancárková N; Krkavcová M; Janashia M; Freitag P
Ceska Gynekol; 2006 May; 71(3):252-9. PubMed ID: 16768055
[TBL] [Abstract][Full Text] [Related]
12. Classification of surface epithelial neoplasms of the ovary.
Hendrickson MR; Longacre TA
Pathology (Phila); 1993; 1(2):189-254. PubMed ID: 9420920
[TBL] [Abstract][Full Text] [Related]
13. Human telomerase reverse transcriptase expression in ovarian tumors.
Maraei AA; Hatta AZ; Shiran MS; Tan GC
Indian J Pathol Microbiol; 2012; 55(2):187-91. PubMed ID: 22771641
[TBL] [Abstract][Full Text] [Related]
14. Gene-expression profiling in epithelial ovarian cancer.
Konstantinopoulos PA; Spentzos D; Cannistra SA
Nat Clin Pract Oncol; 2008 Oct; 5(10):577-87. PubMed ID: 18648354
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
16. [Importance of clinical prognostic factors in the treatment of ovarian carcinoma].
Spacek J; Petera J; Tesarík Z
Ceska Gynekol; 2002 Sep; 67(5):280-5. PubMed ID: 12434665
[TBL] [Abstract][Full Text] [Related]
17. Expression of PTEN in ovarian epithelial tumors and its relation to tumor behavior and growth.
Lee JS; Choi YD; Choi C; Lee MC; Park CS; Min KW
Anal Quant Cytol Histol; 2005 Aug; 27(4):202-10. PubMed ID: 16220831
[TBL] [Abstract][Full Text] [Related]
18. [Risk-reducing surgery in women at hereditary risk of gynaecological cancer].
Zikán M
Ceska Gynekol; 2011 Jun; 76(3):216-21. PubMed ID: 21838153
[TBL] [Abstract][Full Text] [Related]
19. [Importance of chromosomal changes correlated to prognostic factors in ovarian and cervical malignant tumors].
Jancárková N; Krkavcová M; Janashia M; Freitag P; Dusková J; Cibula D
Ceska Gynekol; 2008 Apr; 73(2):79-86. PubMed ID: 18567425
[TBL] [Abstract][Full Text] [Related]
20. Survival in ovarian cancer patients by histology and family history.
Ji J; Försti A; Sundquist J; Lenner P; Hemminki K
Acta Oncol; 2008; 47(6):1133-9. PubMed ID: 18607880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
